Home » Stocks » ZBH

Zimmer Biomet Holdings, Inc. (ZBH)

Stock Price: $150.87 USD 0.85 (0.56%)
Updated November 30, 11:53 AM EST - Market open

Stock Price Chart

Key Info

Market Cap 31.27B
Revenue (ttm) 7.06B
Net Income (ttm) -151.90M
Shares Out 207.28M
EPS (ttm) -0.74
PE Ratio n/a
Forward PE 18.94
Dividend $0.96
Dividend Yield 0.64%

Stock Quote

Trading Day November 30
Last Price $150.87
Previous Close $150.02
Change ($) 0.85
Change (%) 0.56%
Day's Open 150.24
Day's Range 148.87 - 150.96
Day's Volume 201,476
52-Week Range 80.12 - 159.39

More Stats

Market Cap 31.27B
Enterprise Value 38.59B
Earnings Date (est) n/a
Ex-Dividend Date Sep 29, 2020
Shares Outstanding 207.28M
Float n/a
EPS (basic) -0.73
EPS (diluted) -0.74
FCF / Share 3.68
Dividend $0.96
Dividend Yield 0.64%
Earnings Yield n/a
FCF Yield 2.44%
Payout Ratio n/a
Shares Short 2.02M
Short Ratio 1.57
Short % of Float n/a
Beta 1.34
PE Ratio n/a
Forward PE 18.94
P/FCF Ratio 41.04
PS Ratio 4.43
PB Ratio 2.61
Revenue 7.06B
Operating Income 8.30M
Net Income -151.90M
Free Cash Flow 761.90M
Net Cash -7.32B
Net Cash / Share -35.33
Gross Margin 81.10%
Operating Margin 0.12%
Profit Margin -2.20%
FCF Margin 10.78%
ROA 2.36%
ROE -1.25%
ROIC 0.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (29)

Buy 19
Overweight 1
Hold 8
Underweight 0
Sell 1

Analyst Consensus: Buy

Price Target

$157.35*
(4.30% upside)
Low
106
Current: $150.87
High
175
Target: 157.35
*Average 12-month price target from 26 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue7,9827,9337,8037,6685,9984,6734,6234,4724,4524,220
Revenue Growth0.62%1.66%1.76%27.85%28.34%1.08%3.39%0.45%5.49%-
Gross Profit5,7305,6615,6705,2874,1973,4313,3573,3473,3303,208
Operating Income1,13833.807998214671,0371,0691,0471,024917
Net Income1,132-3791,814306147720780755761597
Shares Outstanding205204202200187169170175188200
Earnings Per Share5.47-1.868.901.510.774.204.544.294.032.97
EPS Growth--489.4%96.1%-81.67%-7.49%5.83%6.45%35.69%-
Dividend Per Share0.960.960.960.960.880.880.800.72--
Dividend Growth0%0%0%9.09%0%10%11.11%---
Operating Cash Flow1,5861,7471,5821,6328501,0619631,1521,1771,194
Capital Expenditures-721-439-493-530-364-342-293-264-269-280
Free Cash Flow8651,3081,0891,102486718670888908913
Cash & Equivalents6185435246341,6241,6961,8081,5561,224934
Total Debt8,2218,93910,14311,24111,4971,4261,6721,8211,7191,142
Net Cash / Debt-7,604-8,396-9,618-10,607-9,874270135-265-496-208
Assets24,63924,12726,01426,68427,1619,6589,5819,0128,5158,000
Liabilities12,24612,85114,27917,01517,2713,1063,2813,1463,0012,229
Book Value12,38811,27111,7369,6699,8886,5506,2975,8615,5075,771
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zimmer Biomet Holdings, Inc.
Country United States
Employees 19,900
CEO Bryan C. Hanson

Stock Information

Ticker Symbol ZBH
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: ZBH

Description

Zimmer Biomet Holdings, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and office based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.